高雄醫學大學圖書館 |

Utilizing Zebrafish for a Multifaceted Approach to Modulate Lipid Metabolism in Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Utilizing Zebrafish for a Multifaceted Approach to Modulate Lipid Metabolism in Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma // Chad Hilton VanSant-Webb.
Author:	VanSant-Webb, Chad Hilton,
Description:	1 electronic resource (209 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 86-05, Section: B.
基督教聖經之智慧書導讀 :	Liver cancer or hepatocellular carcinoma (HCC) is a leading cause of cancer-related death with a poor prognosis and short 5-year survival. Metabolic disorders such as obesity and metabolic-dysfunction-associated steatotic liver disease (MASLD) are associated with a 2-fold increase of risk of developing HCC. Since the incidence of obesity and MASLD have and will continue to increase, the incidence of HCC is increasing as well. Much like the tumors themselves, HCC as a whole is a heterogeneous disease with a diverse array of risk factors and etiologies that are uniquely exacerbated by social inequalities, which has made the field of HCC research particularly challenging.To address the central role that dysregulated metabolism plays in disease risk and progression and to acknowledge these challenges, the strength of zebrafish was leveraged to model lipid metabolism using a multi-faceted approach. Herein a transgenic model of activated β-catenin-driven (ABC) HCC that recapitulates disease as seen in 30-40% of human HCC was utilized to describe new methods to identify the effects of ABC on lipid metabolic reprogramming, to screen metabolic inhibitors to identify potential therapeutic targets and uncover molecular mechanisms of disease, and to characterize and model the dysregulation of microRNAs on the hepatocyte transcriptome. Unexpectedly, this research uncovered a potentially unifying theme, the potential of sex-based differences in lipid metabolism and inflammation, which is concordant with what has been documented in higher mammals and humans.
Contained By:	Dissertations Abstracts International86-05B.
Subject:	Nutrition. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31301852
ISBN:	9798342714556

Utilizing Zebrafish for a Multifaceted Approach to Modulate Lipid Metabolism in Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma /
VanSant-Webb, Chad Hilton,

Utilizing Zebrafish for a Multifaceted Approach to Modulate Lipid Metabolism in Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma /Chad Hilton VanSant-Webb. - 1 electronic resource (209 pages)

Source: Dissertations Abstracts International, Volume: 86-05, Section: B.

Liver cancer or hepatocellular carcinoma (HCC) is a leading cause of cancer-related death with a poor prognosis and short 5-year survival. Metabolic disorders such as obesity and metabolic-dysfunction-associated steatotic liver disease (MASLD) are associated with a 2-fold increase of risk of developing HCC. Since the incidence of obesity and MASLD have and will continue to increase, the incidence of HCC is increasing as well. Much like the tumors themselves, HCC as a whole is a heterogeneous disease with a diverse array of risk factors and etiologies that are uniquely exacerbated by social inequalities, which has made the field of HCC research particularly challenging.To address the central role that dysregulated metabolism plays in disease risk and progression and to acknowledge these challenges, the strength of zebrafish was leveraged to model lipid metabolism using a multi-faceted approach. Herein a transgenic model of activated β-catenin-driven (ABC) HCC that recapitulates disease as seen in 30-40% of human HCC was utilized to describe new methods to identify the effects of ABC on lipid metabolic reprogramming, to screen metabolic inhibitors to identify potential therapeutic targets and uncover molecular mechanisms of disease, and to characterize and model the dysregulation of microRNAs on the hepatocyte transcriptome. Unexpectedly, this research uncovered a potentially unifying theme, the potential of sex-based differences in lipid metabolism and inflammation, which is concordant with what has been documented in higher mammals and humans.

English

ISBN: 9798342714556Subjects--Topical Terms:

192833
Nutrition.
Subjects--Index Terms:

Hepatocellular carcinoma

Utilizing Zebrafish for a Multifaceted Approach to Modulate Lipid Metabolism in Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma /
LDR:03131nam a22004213i 4500 001 391442
005 20251124054757.5
006 m o d
007 cr|nu||||||||
008 251208s2024 miu||||||m |||||||eng d
020 $a 9798342714556
035 $a (MiAaPQD)AAI31301852
035 $a AAI31301852
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a VanSant-Webb, Chad Hilton, $e author. $3 523925
245 1 0 $a Utilizing Zebrafish for a Multifaceted Approach to Modulate Lipid Metabolism in Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma / $c Chad Hilton VanSant-Webb.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (209 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-05, Section: B.
500 $a Advisors: Evason, Kimberley Committee members: O'Connell, Ryan M.; Spike, Benjamin T.; Stewart, Rodney A.; Formosa, Timothy.
502 $b D.Phil. $c The University of Utah $d 2024.
520 $a Liver cancer or hepatocellular carcinoma (HCC) is a leading cause of cancer-related death with a poor prognosis and short 5-year survival. Metabolic disorders such as obesity and metabolic-dysfunction-associated steatotic liver disease (MASLD) are associated with a 2-fold increase of risk of developing HCC. Since the incidence of obesity and MASLD have and will continue to increase, the incidence of HCC is increasing as well. Much like the tumors themselves, HCC as a whole is a heterogeneous disease with a diverse array of risk factors and etiologies that are uniquely exacerbated by social inequalities, which has made the field of HCC research particularly challenging.To address the central role that dysregulated metabolism plays in disease risk and progression and to acknowledge these challenges, the strength of zebrafish was leveraged to model lipid metabolism using a multi-faceted approach. Herein a transgenic model of activated β-catenin-driven (ABC) HCC that recapitulates disease as seen in 30-40% of human HCC was utilized to describe new methods to identify the effects of ABC on lipid metabolic reprogramming, to screen metabolic inhibitors to identify potential therapeutic targets and uncover molecular mechanisms of disease, and to characterize and model the dysregulation of microRNAs on the hepatocyte transcriptome. Unexpectedly, this research uncovered a potentially unifying theme, the potential of sex-based differences in lipid metabolism and inflammation, which is concordant with what has been documented in higher mammals and humans.
546 $a English
590 $a School code: 0240
650 4 $2 96060 $a Nutrition. $3 192833
650 4 $a Health sciences. $3 523815
650 4 $2 96060 $a Oncology. $3 273823
653 $a Hepatocellular carcinoma
653 $a Liver
653 $a Metabolism
653 $a miRNA
690 $a 0992
690 $a 0566
690 $a 0570
710 2 $a The University of Utah. $b Oncological Sciences. $e degree granting institution. $3 523926
720 1 $a Evason, Kimberley $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-05B.
790 $a 0240
791 $a D.Phil.
792 $a 2024
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31301852